Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp > 0.27

<< Previous

Bullboard Posts

Next >>

Comment by jimmyhorizonon Feb 10, 2022 8:04am

111 Views

Post# 34415669

RE:RE:RE:RE:RE:RE:RE:0.27

All good and good morning.

how i jump on it?

i'm probably damaged from years of sirona corporate communication. then you read way too much out of every reference or non-event.

normally you don't believe a liar anymore.

you have a big advantage wexi, you can be wrong 1000 times and only have to be right once.

we will see. if it comes as it is insinuated, then we are all happy and you are my hero.

<< Previous

Bullboard Posts

Next >>

The top TSX healthcare stocks under $1